Presentation | July 17, 2024

Orally-Disintegrating Dosage Forms With Taste Masked Multiparticulates

Tablet Dissolving GettyImages-851893518

Adare Pharma Solutions, a leading pharmaceutical company, has developed orally disintegrating dosage forms (ODDFs) that contain taste-masked multiparticulates. With their expertise in ODDFs and taste-masking technologies, Adare Pharma Solutions offers a range of solutions for complex oral dosage forms. We specialize in product development and GMP commercial manufacturing, serving as a trusted partner to over 100 pharmaceutical companies worldwide.

These products encompass prescription and over-the-counter medications for adults and children. Adare Pharma Solutions aims to provide the appropriate medication to the correct patient in the most suitable dosage form. One of our notable developments is the orally disintegrating tablet (ODT) platform called Advatab®, which offers optimized taste and controlled release particles. These tablets are ideal for patients who have difficulty swallowing or sensitive taste preferences, such as pediatric, geriatric, and dysphagic patients. The taste-masked and controlled release particles ensure improved patient adherence, while the rapid disintegration and smooth mouthfeel enhance convenience and acceptance.

Adare Pharma Solutions also offers taste-masking technologies like Microcaps® and Optimµm®, which efficiently mask the bitter taste of drugs. These technologies can be converted into patient-centric ODT dosage forms, providing a convenient and accepted solution for various patient populations. ODTs with taste-masked multiparticulates have the potential to improve acceptance, adherence, and compliance in pharmacotherapy.

access the Presentation!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.

Subscribe to Drug Delivery Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Delivery Leader